These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17924846)

  • 1. The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients.
    Picheth G; Costantini CO; Pedrosa FO; Leme da Rocha Martinez T; Maltempi de Souza E
    Clin Chem Lab Med; 2007; 45(10):1268-72. PubMed ID: 17924846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
    Bansal S; Chawla D; Banerjee BD; Madhu SV; Tripathi AK
    Gene; 2013 Sep; 526(2):325-30. PubMed ID: 23721855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus.
    Peng WH; Lu L; Wang LJ; Yan XX; Chen QJ; Zhang Q; Zhang RY; Shen WF
    Arch Med Res; 2009 Jul; 40(5):393-8. PubMed ID: 19766904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes.
    Kirbis J; Milutinović A; Steblovnik K; Teran N; Terzić R; Zorc M
    Coll Antropol; 2004 Dec; 28(2):611-6. PubMed ID: 15666591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease.
    Kucukhuseyin O; Aydogan HY; Isbir CS; Isbir T
    In Vivo; 2009; 23(6):949-54. PubMed ID: 20023238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease.
    Falcone C; Campo I; Emanuele E; Buzzi MP; Zorzetto M; Sbarsi I; Cuccia M
    Int J Mol Med; 2004 Dec; 14(6):1061-4. PubMed ID: 15547674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement.
    Falcone C; Emanuele E; Buzzi MP; Ballerini L; Repetto A; Canosi U; Mazzucchelli I; Schirinzi S; Sbarsi I; Boiocchi C; Cuccia M
    Int J Immunopathol Pharmacol; 2007; 20(4):771-7. PubMed ID: 18179750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes.
    dos Santos KG; Canani LH; Gross JL; Tschiedel B; Pires Souto KE; Roisenberg I
    Mol Genet Metab; 2005 Jun; 85(2):149-56. PubMed ID: 15896660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis of -429T/C and -374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy.
    Ng ZX; Kuppusamy UR; Tajunisah I; Fong KC; Chua KH
    Diabetes Res Clin Pract; 2012 Mar; 95(3):372-7. PubMed ID: 22154374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients.
    Aydoğan HY; Küçükhüseyin O; Tekeli A; Isbir T
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):134-7. PubMed ID: 21861709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the receptor for advanced glycation end products gene polymorphisms with diabetic retinopathy in type 2 diabetes: a meta-analysis.
    Yuan D; Yuan D; Liu Q
    Ophthalmologica; 2012; 227(4):223-32. PubMed ID: 22354095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor for advanced glycation end products (RAGE) gene polymorphism and cardiovascular disease in end-stage renal disease patients.
    Buraczynska M; Zaluska W; Buraczynska K; Markowska-Gosik D; Ksiazek A
    Hum Immunol; 2015 Nov; 76(11):843-8. PubMed ID: 26429324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between the -374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studies.
    Engelen L; Ferreira I; Gaens KH; Henry RM; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; van Greevenbroek MM; van der Kallen CJ; Blaak EE; Feskens EJ; Ten Cate H; Stehouwer CD; Schalkwijk CG
    J Hypertens; 2010 Feb; 28(2):285-93. PubMed ID: 20051912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: a meta-analysis.
    Lu W; Feng B
    Tohoku J Exp Med; 2010 Apr; 220(4):291-7. PubMed ID: 20410680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. -374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis.
    Falcone C; Campo I; Emanuele E; Buzzi MP; Geroldi D; Belvito C; Zorzetto M; Sbarsi I; Cuccia M
    Clin Chim Acta; 2005 Apr; 354(1-2):111-6. PubMed ID: 15748606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy.
    Ng ZX; Kuppusamy UR; Iqbal T; Chua KH
    Gene; 2013 Jun; 521(2):227-33. PubMed ID: 23545311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of the promoter and exon 3 of the receptor for advanced glycation end products (RAGE) in Euro- and Afro-Brazilians.
    Torres MC; Beltrame MH; Santos IC; Picheth G; Petzl-Erler ML; Pedrosa FO; Steffens MB; de Souza EM
    Int J Immunogenet; 2012 Apr; 39(2):155-60. PubMed ID: 22133449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for advanced glycation end products polymorphisms in coronary artery ectasia.
    Aslan EI; Ozkara G; Kilicarslan O; Ser OS; Bostan C; Yildiz A; Diren Borekcioglu A; Ozturk O; Kucukhuseyin O; Yilmaz Aydogan H
    Gene; 2024 Jul; 916():148450. PubMed ID: 38588932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
    Däbritz J; Friedrichs F; Weinhage T; Hampe J; Kucharzik T; Lügering A; Broeckel U; Schreiber S; Spieker T; Stoll M; Foell D
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G823-32. PubMed ID: 21311028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional promoter polymorphisms of the receptor for advanced glycation end products in children and adolescents with type 1 diabetes.
    Gomes LC; Welter M; Gobor LC; Santos-Weiss ICR; França SN; Alberton D; Picheth G; Rego FG
    Mol Cell Probes; 2015 Dec; 29(6):503-506. PubMed ID: 26456846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.